Boston Scientific (BSX) Cash & Equivalents Growth (1y) (2010 - 2026)
Powered by 
Analysis
Boston Scientific (BSX) Cash & Equivalents Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 177.93 Bn | 7.27 Bn | -26.57% |
| 2 | Intuitive Surgical | 124.70 Bn | 119.48 Bn | 1.96 Bn | -19.91% |
| 3 | Medtronic | 117.91 Bn | 109.09 Bn | 6.34 Bn | 32.84% |
| 4 | Stryker | 105.72 Bn | 102.25 Bn | 4.50 Bn | 42.78% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 0.94% |
| 6 | Edwards Lifesciences | 49.52 Bn | 45.27 Bn | 1.35 Bn | -11.19% |
| 7 | Alcon | 33.89 Bn | 32.43 Bn | 1.68 Bn | -3.76% |
| 8 | Dexcom | 32.10 Bn | 30.15 Bn | 830.00 Mn | -4.66% |
| 9 | Steris | 21.06 Bn | 20.58 Bn | 684.20 Mn | 72.43% |
| 10 | Zimmer Biomet Holdings | 18.26 Bn | 17.85 Bn | 1.54 Bn | -26.38% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.94% |
| Mar 31, 2026 | 100.41% |
| Dec 31, 2025 | 224.26% |
| Sep 30, 2025 | -49.04% |
| Jun 30, 2025 | -81.67% |
| Mar 31, 2025 | -68.87% |
| Dec 31, 2024 | -29.94% |
| Sep 30, 2024 | 162.82% |
| Jun 30, 2024 | 583.80% |
| Mar 31, 2024 | 308.60% |
| Dec 31, 2023 | -6.79% |
| Sep 30, 2023 | 181.66% |
| Jun 30, 2023 | 54.35% |
| Mar 31, 2023 | 75.38% |
| Dec 31, 2022 | -51.79% |
| Sep 30, 2022 | -82.64% |
| Jun 30, 2022 | -89.68% |
| Mar 31, 2022 | -83.88% |
| Dec 31, 2021 | 11.01% |
| Sep 30, 2021 | -3.71% |